Section Arrow
Quote
BHVN.NYSE
- Biohaven Ltd
Quotes are at least 15-min delayed:2026/02/10 12:42 EST
Regular Hours
Last
 12.46
-0.32 (-2.50%)
Day High 
13.0799 
Prev. Close
12.78 
1-M High
14.0069 
Volume 
805.02K 
Bid
12.45
Ask
12.47
Day Low
12.3568 
Open
13 
1-M Low
10.35 
Market Cap 
1.70B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 11.81 
20-SMA 12.16 
50-SMA 11.23 
52-W High 42.33 
52-W Low 7.48 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-7.52/-1.46
Enterprise Value
1.73B
Balance Sheet
Book Value Per Share
-0.13
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QNCXQuince Therapeutics0.4314+0.3014+231.85%-- 
PHIOPhio Pharmaceuticals Corp1.315+0.415+46.11%-- 
ABPAbpro Holdings Inc1.9399+0.4199+27.63%-- 
IBRXImmunityBio7+0.07+1.01%-- 
HUMAHumacyte1.11-0.11-9.02%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.